4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000060
Director sold 1,666 shares at an average $65.13 ($108,510)
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-21 | Sale : show line 1 in the form | −400 | $64.25 | $25,700 | 134,097 | D |
| 2021-07-21 | Sale : show line 2 in the form | −866 | $65.24 | $56,498 | 133,231 | D |
| 2021-07-21 | Sale : show line 3 in the form | −400 | $65.78 | $26,312 | 132,831 | D |
| Open-market sales · 1,666 sh · avg $65.13 · $108,510 | ||||||
Loading xslF345X03/wf-form4_162707596730665.xml…